Research on feasibility and efficacy of Group Cognitive Processing Therapy for posttraumatic stress disorder in Japa
- Conditions
- Posttraumatic Stress Disorder (PTSD)
- Registration Number
- JPRN-UMIN000012919
- Lead Sponsor
- Musashino University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 25
Not provided
1.Those who cannot continue the treatment due to concurrent psychiatric disorders (ex. schizophrenia, bipolar disorder alcohol /drug related disorder, A cluster personality disorder etc.)and severe self-destructive symptoms(self-injury or suicidal attempt) 2.Those who have a history of epilepsy and whose EEG has not been normalized 3.Those who have too severe cognitive dysfunctions to do CPT sessions 4.Physical disease that may interfere psychological treatment 5.Those who have already received cognitive behavioral treatment for traumatic symptoms, or currently receive it 6.Those who cannot go to the hospital regularly(the absence rate of treatment periods > 50%) 7.Those who are judged by the screening doctors due to other reasons, such as pregnant, difficulty in understanding the procedure of the study or treatment protocol due to illiteracy or intellectual problem, ongoing or scheduled court litigation for which PTSD works favorably (excluding arbitration or litigation for divorce), and etc. 8.Those who have long history of sexual abuse in their own family.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Clinical Administered Scale for PTSD (CAPS)
- Secondary Outcome Measures
Name Time Method 1. Mini-International Neuropsychiatric Interview (M.I.N.I) 2.Impact of Event Scale Revised (IES-R) 3. Beck Depression Inventory-II (BDI-II) 4. Trauma Related Guilt Inventory (TRGI) 5. Trauma Related Guilt Inventory (TRGI) 6. Short Form 8 (SF-8) 7. Dissociative Experiences Scale (DES) 8. Overall Anxiety Severity and Impairment Scale (OASIS) 9. Dropout rate 10. Emergence of adverse event